KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) EBIT: 2009-2014

Historic EBIT for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2014 value amounting to -$45.8 million.

  • Biocryst Pharmaceuticals' EBIT fell 13.37% to -$13.2 million in Q3 2015 from the same period last year, while for Sep 2015 it was -$37.4 million, marking a year-over-year decrease of 1.24%. This contributed to the annual value of -$45.8 million for FY2014, which is 49.01% down from last year.
  • As of FY2014, Biocryst Pharmaceuticals' EBIT stood at -$45.8 million, which was down 49.01% from -$30.7 million recorded in FY2013.
  • Biocryst Pharmaceuticals' EBIT's 5-year high stood at -$30.7 million during FY2013, with a 5-year trough of -$49.6 million in FY2011.
  • Its 3-year average for EBIT is -$36.8 million, with a median of -$33.9 million in 2012.
  • Its EBIT has fluctuated over the past 5 years, first tumbled by 150.11% in 2010, then soared by 31.66% in 2012.
  • Over the past 5 years, Biocryst Pharmaceuticals' EBIT (Yearly) stood at -$34.4 million in 2010, then crashed by 44.33% to -$49.6 million in 2011, then soared by 31.66% to -$33.9 million in 2012, then rose by 9.36% to -$30.7 million in 2013, then crashed by 49.01% to -$45.8 million in 2014.